HUNT RONALD

CIK 000124785116 companiesNEW HAVEN, CT

SEC Profile

Transactions

Companies

Filings

CIK

0001247851

Recent Transactions

50 trades

Award
Rallybio Corp$RLYB
Option (Right to Buy)
2026-02-18$3.60/sh+14,305→ 14,305 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2025-05-13+28,500→ 28,500 total
Other
Iterum Therapeutics plc$ITRM
6.500% Exchangeable Senior Subordinated Note due 2025
2025-01-13$2208000.00/sh
Other
Iterum Therapeutics plc$ITRM
6.500% Exchangeable Senior Subordinated Note due 2025
2025-01-13$792000.00/sh
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2025-01-02$0.70/sh+73,571→ 73,571 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2024-08-06+182,453→ 253,898 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+182,453→ 182,453 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+182,453→ 182,453 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+65,481→ 65,481 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Subscription Rights (right to buy)
2024-08-06−364,906→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2024-08-06+65,481→ 91,122 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Warrants (right to buy)
2024-08-06+65,481→ 65,481 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Subscription Rights (right to buy)
2024-08-06−130,962→ 0 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2024-05-15+16,500→ 16,500 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−13,224→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2024-03-11−85,750→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−2,300→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−1,016→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−395,783→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−3,214→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2024-03-11−2,033→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock
2024-03-11−1,463,386→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2024-03-11−686,000→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2024-03-11−299,430→ 0 total
Disposition to Issuer
Harpoon Therapeutics, Inc.
8.000% Series A Redeemable Preferred Stock
2024-03-11−10,000→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-03-08+424→ 13,224 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2024-01-02$1.77/sh+29,096→ 29,096 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2024-01-01+1,072→ 12,801 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-11-27+5,000→ 11,729 total
Purchase
Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2023-10-25+85,750→ 85,750 total
Purchase
Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2023-10-25+686,000→ 686,000 total
Purchase
Harpoon Therapeutics, Inc.
Common Stock
2023-10-25+1,372,000→ 1,463,386 total
Purchase
Harpoon Therapeutics, Inc.
Common Stock
2023-10-25+171,500→ 395,783 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-10-01+3,035→ 6,729 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-10-01+5,479→ 14,346 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-10-01−5,479→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-07-01+2,796→ 8,867 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-07-01+18,656→ 36,941 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-07-01−2,796→ 0 total
Award
Harpoon Therapeutics, Inc.
Director Stock Option (Right to Buy)
2023-06-22+23,000→ 23,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2023-05-17+15,490→ 15,490 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-04-01+2,041→ 6,071 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-04-01−2,041→ 0 total
Award
Harpoon Therapeutics, Inc.
Common Stock
2023-04-01+18,285→ 18,285 total
Purchase
Harpoon Therapeutics, Inc.
Common Stock Warrant (Right to Buy)
2023-03-23+2,994,305→ 2,994,305 total
Purchase
Harpoon Therapeutics, Inc.
8.000% Series A Redeemable Preferred Stock
2023-03-23$1000.00/sh+10,000→ 10,000 total
Award
Rallybio Corp$RLYB
Option (Right to Buy)
2023-01-03+11,099→ 11,099 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Restricted Share Units
2023-01-01−1,197→ 0 total
Exercise/Conversion
Iterum Therapeutics plc$ITRM
Ordinary Shares
2023-01-01+1,197→ 4,030 total
Award
Iterum Therapeutics plc$ITRM
Restricted Share Units
2022-12-23+5,479→ 5,479 total

HUNT RONALD

Recent Transactions

Companies

Recent Filings

Address